Literature DB >> 10850392

Mechanisms of cocaine hydrolysis and metabolism in vitro and in vivo: a clarification.

A Warner1, A B Norman.   

Abstract

There is confusion in the literature concerning the mechanisms by which the cocaine hydrolysis product, benzoylecgonine (BE), is formed in vitro and in vivo. Some authors assume that all BE is formed nonenzymatically. This review summarizes evidence that both enzymatic and nonenzymatic mechanisms exist. In vitro BE is produced exclusively by hydrolysis at alkaline pH, as esterases present in blood or serum do not catalyze formation of BE. In vivo BE is formed both nonenzymatically as well as through the action of esterases found in a number of tissues including hepatocytes. The enzymatic mechanism is the predominant one operating in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10850392     DOI: 10.1097/00007691-200006000-00006

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  14 in total

1.  Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers.

Authors:  Jennifer L Donovan; C Lindsay DeVane; Robert J Malcolm; Jurij Mojsiak; C Nora Chiang; Ahmed Elkashef; Robin M Taylor
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Mechanisms of acute cocaine toxicity.

Authors:  Kennon Heard; Robert Palmer; Nancy R Zahniser
Journal:  Open Pharmacol J       Date:  2008

3.  Characterization of a recombinant humanized anti-cocaine monoclonal antibody produced from multiple clones for the selection of a master cell bank candidate.

Authors:  Hanna N Wetzel; Rose P Webster; Fatima O Saeed; Terence L Kirley; William J Ball; Andrew B Norman
Journal:  Biochem Biophys Res Commun       Date:  2017-04-23       Impact factor: 3.575

4.  Competitive dopamine receptor antagonists increase the equiactive cocaine concentration during self-administration.

Authors:  Andrew B Norman; Mantana K Norman; Michael R Tabet; Vladimir L Tsibulsky; Amadeo J Pesce
Journal:  Synapse       Date:  2010-10-08       Impact factor: 2.562

5.  Structural analysis of free and liganded forms of the Fab fragment of a high-affinity anti-cocaine antibody, h2E2.

Authors:  Kemin Tan; Min Zhou; Angela J Ahrendt; Norma E C Duke; Nassif Tabaja; William J Ball; Terence L Kirley; Andrew B Norman; Andrzej Joachimiak; Marianne Schiffer; Rosemarie Wilton; P Raj Pokkuluri
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-11-05       Impact factor: 1.056

6.  Bioavailability and Pharmacokinetics of Oral Cocaine in Humans.

Authors:  Marion A Coe; Rebecca A Jufer Phipps; Edward J Cone; Sharon L Walsh
Journal:  J Anal Toxicol       Date:  2018-06-01       Impact factor: 3.367

Review 7.  Anti-cocaine vaccine development.

Authors:  Berma M Kinsey; Thomas R Kosten; Frank M Orson
Journal:  Expert Rev Vaccines       Date:  2010-09       Impact factor: 5.217

8.  A recombinant humanized anti-cocaine monoclonal antibody inhibits the distribution of cocaine to the brain in rats.

Authors:  Andrew B Norman; Felicia C T Gooden; Michael R Tabet; William J Ball
Journal:  Drug Metab Dispos       Date:  2014-04-14       Impact factor: 3.922

9.  Real-time cellular exometabolome analysis with a microfluidic-mass spectrometry platform.

Authors:  Christina C Marasco; Jeffrey R Enders; Kevin T Seale; John A McLean; John P Wikswo
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

Review 10.  The Health Effect of Psychostimulants: A Literature Review.

Authors:  Thierry Favrod-Coune; Barbara Broers
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.